Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TACROLIMUS SANDOZ CAPSULE 0.5 MG

Approval Number

SIN15673P

Drug Name

TACROLIMUS SANDOZ CAPSULE 0.5 MG

Product Name

TACROLIMUS SANDOZ CAPSULE 0.5 MG

Approval Date

April 25, 2019

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE, GELATIN COATED

Route of Administration

ORAL

Medical Information

ATC Code

L04AD02

ATC Item Name

tacrolimus

Manufacturer Information

Pharmaceutical Manufacturer

SANDOZ SINGAPORE PTE. LTD.

Manufacturers

Sandoz Private Limited

Active Ingredients

Ingredient Name

Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus

Strength

0.5 mg

Drug MonographTacrolimus

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

TACROLIMUS SANDOZ CAPSULE 0.5 MG - HSA Approval | MedPath